HAVCR2 and neoplasm: Over-expression of coinhibitory molecules, such as CTLA-4, PD-1, and Tim-3, often results in the functional inhibition or exhaustion of T cells, reversing which by antibodies gives rise to the promising therapeutic modality in tumor, called checkpoint immunotherapy35.